Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
10X Genomics Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
TXG
Nasdaq
2836
https://www.10xgenomics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for 10X Genomics Inc
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
- Mar 26th, 2024 1:00 pm
10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
- Mar 21st, 2024 8:05 pm
10x Genomics Begins Commercial Shipments of Chromium GEM-X Products
- Mar 13th, 2024 8:05 pm
11 Oversold Healthcare Stocks To Buy Right Now
- Mar 13th, 2024 12:17 pm
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
- Mar 1st, 2024 7:00 pm
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
- Feb 27th, 2024 4:55 pm
10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference
- Feb 20th, 2024 9:05 pm
10x Genomics, Inc. (NASDAQ:TXG) Q4 2023 Earnings Call Transcript
- Feb 16th, 2024 3:21 pm
Q4 2023 10X Genomics Inc Earnings Call
- Feb 16th, 2024 1:14 pm
Here's What Key Metrics Tell Us About 10x Genomics (TXG) Q4 Earnings
- Feb 15th, 2024 11:00 pm
10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates
- Feb 15th, 2024 10:20 pm
10x Genomics Inc (TXG) Reports Solid Revenue Growth Amid Rising Operating Expenses in FY 2023
- Feb 15th, 2024 9:40 pm
10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024
- Feb 15th, 2024 9:05 pm
10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
- Feb 8th, 2024 3:00 pm
10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology
- Feb 7th, 2024 9:05 pm
10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting
- Feb 5th, 2024 9:05 pm
Nanostring files for bankruptcy protection, explores possible sale
- Feb 5th, 2024 4:18 pm
Companies Like 10x Genomics (NASDAQ:TXG) Are In A Position To Invest In Growth
- Jan 27th, 2024 12:25 pm
10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
- Jan 24th, 2024 9:05 pm
10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results
- Jan 8th, 2024 2:00 pm
Scroll